The global market for Proteomics is estimated at US$34.1 Billion in 2023 and is projected to reach US$66.7 Billion by 2030, growing at a CAGR of 10.1% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the proteomics market is driven by several factors. The increasing prevalence of chronic diseases such as cancer and cardiovascular diseases has heightened the demand for advanced diagnostic and therapeutic solutions, spurring the adoption of proteomics. The shift towards personalized medicine, which relies on understanding individual proteomic profiles to tailor treatments, is also a significant driver. Factors supporting growth also include development of protein targeted treatments and precision molecular medicines for many autoimmune diseases, development of mass spectrometry-based proteomics, and development of molecular targets in malignancies. Increasing focus of biotechnological and pharmaceutical companies in research and development for identifying new proteomics applications, development of new drugs, and proteomics biomarker discovery in different types of diseases such as cardiovascular diseases and cancer is the major trend in the global proteomics landscape. Technological advancements in mass spectrometry and bioinformatics are enhancing the capabilities of proteomic analysis, making it more accessible and cost-effective. Furthermore, the expansion of research in areas such as biomarker discovery and drug development is fueling market growth. Government and private sector investments in proteomics research and infrastructure, coupled with collaborations between academic institutions and pharmaceutical companies, are also contributing to the market`s expansion. These factors, along with the growing recognition of proteomics as a critical tool in life sciences research, are propelling the growth of the proteomics market.
The growth in the proteomics market is driven by several factors. The increasing prevalence of chronic diseases such as cancer and cardiovascular diseases has heightened the demand for advanced diagnostic and therapeutic solutions, spurring the adoption of proteomics. The shift towards personalized medicine, which relies on understanding individual proteomic profiles to tailor treatments, is also a significant driver. Factors supporting growth also include development of protein targeted treatments and precision molecular medicines for many autoimmune diseases, development of mass spectrometry-based proteomics, and development of molecular targets in malignancies. Increasing focus of biotechnological and pharmaceutical companies in research and development for identifying new proteomics applications, development of new drugs, and proteomics biomarker discovery in different types of diseases such as cardiovascular diseases and cancer is the major trend in the global proteomics landscape. Technological advancements in mass spectrometry and bioinformatics are enhancing the capabilities of proteomic analysis, making it more accessible and cost-effective. Furthermore, the expansion of research in areas such as biomarker discovery and drug development is fueling market growth. Government and private sector investments in proteomics research and infrastructure, coupled with collaborations between academic institutions and pharmaceutical companies, are also contributing to the market`s expansion. These factors, along with the growing recognition of proteomics as a critical tool in life sciences research, are propelling the growth of the proteomics market.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Proteomics Reagents segment, which is expected to reach US$49.2 Billion by 2030 with a CAGR of a 9.9%. The Proteomics Instruments segment is also set to grow at 10.9% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $12.6 Billion in 2023, and China, forecasted to grow at an impressive 12.7% CAGR to reach $6.5 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Proteomics Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Proteomics Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Proteomics Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Active Motif, Inc., 20/20 Genesystems, Inc., BG Medicine, Inc., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 178 Featured):
- Active Motif, Inc.
- 20/20 Genesystems, Inc.
- BG Medicine, Inc.
- BGI-Shenzhen
- Biodesix, Inc.
- Abbiotec LLC
- BioChain Institute, Inc.
- Arbor Vita Corporation
- Biomosaics, Inc.
- Advansta Inc.
- AYOXXA Biosystems GmbH
- AKESOgen, Inc.
- Biognosys
- Biorbyt
- BioAnalyte
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISSOUTH KOREAREST OF ASIA-PACIFICIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
SPAIN
RUSSIA
REST OF EUROPE
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Active Motif, Inc.
- 20/20 Genesystems, Inc.
- BG Medicine, Inc.
- BGI-Shenzhen
- Biodesix, Inc.
- Abbiotec LLC
- BioChain Institute, Inc.
- Arbor Vita Corporation
- Biomosaics, Inc.
- Advansta Inc.
- AYOXXA Biosystems GmbH
- AKESOgen, Inc.
- Biognosys
- Biorbyt
- BioAnalyte
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 577 |
| Published | November 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 34.1 Billion |
| Forecasted Market Value ( USD | $ 66.7 Billion |
| Compound Annual Growth Rate | 10.1% |
| Regions Covered | Global |
